Integrating large language models in care, research, and education in multiple sclerosis management.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
PMID:

Abstract

Use of techniques derived from generative artificial intelligence (AI), specifically large language models (LLMs), offer a transformative potential on the management of multiple sclerosis (MS). Recent LLMs have exhibited remarkable skills in producing and understanding human-like texts. The integration of AI in imaging applications and the deployment of foundation models for the classification and prognosis of disease course, including disability progression and even therapy response, have received considerable attention. However, the use of LLMs within the context of MS remains relatively underexplored. LLMs have the potential to support several activities related to MS management. Clinical decision support systems could help selecting proper disease-modifying therapies; AI-based tools could leverage unstructured real-world data for research or virtual tutors may provide adaptive education materials for neurologists and people with MS in the foreseeable future. In this focused review, we explore practical applications of LLMs across the continuum of MS management as an initial scope for future analyses, reflecting on regulatory hurdles and the indispensable role of human supervision.

Authors

  • Hernan Inojosa
    Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Isabel Voigt
    Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Judith Wenk
    Center of Clinical Neuroscience, Department of Neurology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Dyke Ferber
    Department of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Isabella Wiest
    Else Kröner Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany.
  • Dario Antweiler
    Fraunhofer Institut für Intelligente Analyse und Informationssysteme IAIS, Abteilung Knowledge Discovery, Schloss Birlinghoven 1, 53757, Sankt Augustin, Deutschland. dario.antweiler@iais.fraunhofer.de.
  • Eva Weicken
    Fraunhofer Institute for Telecommunications Heinrich-Hertz-Institute HHI, Berlin, Germany.
  • Stephen Gilbert
    Ada Health GmbH, Berlin, Germany.
  • Jakob Nikolas Kather
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Katja Akgün
    Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Tjalf Ziemssen
    Technische Universität, Dresden, Germany.